The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Centralized analysis of phase II ECG dataset of resminostat, an orally available histone-deacetylase inhibitor (HDACi).
Bernhard Hauns
Employment or Leadership Position - 4SC
Henning Schulze-Bergkamen
No relevant relationships to disclose
Dirk Jaeger
No relevant relationships to disclose
Hans-Georg Kopp
No relevant relationships to disclose
Michael Bitzer
No relevant relationships to disclose
Babett Krauss
Employment or Leadership Position - 4SC
Stefan W. Henning
Employment or Leadership Position - 4SC
Bernd Hentsch
Employment or Leadership Position - 4SC
Wilhelm Haverkamp
No relevant relationships to disclose